UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report: June 20, 2016
NET MEDICAL EXPRESS SOLUTIONS, INC.
(Exact name of Registrant as specified in charter)
NEVADA | 333-30176 | 91-1287406 |
(State or other jurisdiction of incorporation or organization) | (Commission File Number) | (I.R.S. Employer Identification No.) |
5021 Indian School Road, Suite 100
Albuquerque, New Mexico 87110
(Address of principal executive offices) (Zip Code)
(505) 255-1999
(Registrants telephone number, including area code)
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Section 5 - Corporate Governance and Management
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
We amended our Articles of Incorporation on April 18, 2016 for the purpose of effecting a share combination (reverse stock split) in a ratio of one share for each nine shares issued and outstanding. The amendment provides that the effective date is dependent on the market announcement made by the Financial Industry Regulatory Authority. The market announcement was made today. The effective date for market purposes is opening of business on June 21, 2016.
Section 7 - Regulation FD
Item 7.01 Regulation FD Disclosure.
On June 20, 2016, we issued a press release announcing the reverse stock split. The release includes instructions to stockholders for exchange of certificates and payment for fractional shares.
Section 9 - Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. |
|
99 | Press release dated June 20, 2016 |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Net Medical Express Solutions, Inc.
By: /s/ Richard F. Govatski
Richard F. Govatski, President
Date: June 20, 2016
3